Andrew Gaudin: Pharmacy Guild CEO on the reclassification of CBD products - The Mike Hosking Breakfast

A step towards increasing the availability of CBD products. 

CBD is a compound found in marijuana but has little to no psychoactive effects. 

Medsafe has reclassified CBD from prescription only to a restricted medicine, meaning low-dose CBD medicines can be sold by pharmacists. 

But Pharmacy Guild Chief Executive Andrew Gaudin told Mike Hosking that there are currently no low-dose products approved here. 

He says this is the encouragement to manufacturers to start the process of developing products, which they'll then have to demonstrate the benefits of to get them approved. 

LISTEN ABOVE 

See omnystudio.com/listener for privacy information.